MDCX

Medicus Pharma Ltd. Common Stock · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-25

Figures on this page computed 2026-11-08 12:40 UTC

Last close

1.88USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-03-25

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001062993-26-001606
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-25
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001062993-26-001606
Reported in
USD
- 10-K for 2025, filed 2026-03-25
- 10-K for 2025, filed 2026-03-25
- 10-K for 2025, filed 2026-03-25
- 10-Q for 2025, filed 2026-08-12
- 10-K for 2025, filed 2026-03-25
- 10-Q for 2025, filed 2026-08-12
The filing itself
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001062993-26-001606
Reported in
USD
- 10-K for 2025, filed 2026-03-25
- 10-K for 2025, filed 2026-03-25
The filing itself
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001062993-26-001606
Reported in
USD
- 10-K for 2025, filed 2026-03-25
- 10-K for 2025, filed 2026-03-25
- 10-K for 2025, filed 2026-03-25
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001062993-26-001606
Reported in
USD
- 10-K for 2025, filed 2026-03-25
- 10-Q for 2025, filed 2026-08-12
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Safety is the furthest below its sector's middle: 0.20 against 0.72 on the market's range.

Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
Price: n/aWe do not hold this figure for this company, so there is nothing to place.
What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

n/a

3.50x

n/a

2.73x

0.02x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

3 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-25

Salesn/a
Its own average over 0 years.
Profit3.50x
Its own average over 5 years, -13.5M.
Free cash flown/a
Its own average over 2 years, -1.3M.
Debt2.73x
Its own average over 4 years, 2.0M.
Price0.02x
Its own average over 3 years, 93. Market data, 2026-11-04

Profit is furthest from its own average, at 3.50 times.

Profit is 3.50 times its own 5-year average; Debt is 2.73 times its own 4-year average; Price is 0.02 times its own 3-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-25

Sales against its own 0-year averagen/a
Not held.
Source
filed
Statement
income
Fiscal year
2025
Accession
0001062993-26-001606
Reported in
USD
The filing itself
Profit against its own 5-year average3.50
Source
filed
Statement
income
Fiscal year
2025
Accession
0001062993-26-001606
Reported in
USD
The filing itself
Free cash flow against its own 2-year averagen/a
Not held.
Source
filed
Statement
income
Fiscal year
2025
Accession
0001062993-26-001606
Reported in
USD
The filing itself
Debt against its own 4-year average2.73
Source
filed
Statement
income
Fiscal year
2025
Accession
0001062993-26-001606
Reported in
USD
The filing itself
Price against its own 3-year average0.02Market data, 2026-11-04
Source
market
Taken on
2026-11-04
Reported in
USD